Wei Tao - Biography#

Prof. Wei Tao is the Farokhzad Family Distinguished Chair for Innovation (Endowed Chair), Co-Director of Nano Immune-Imaging Core, Principal Investigator in the Center for Nanomedicine, and Faculty Member in the Department of Anesthesiology, Perioperative and Pain Medicine at Brigham and Women’s Hospital (BWH), Harvard Medical School (HMS). He is also the first Distinguished Chair professor as an assistant professor in the history of his institution. He has been continuously named a Clarivate’s Global Highly Cited Researcher since 2021, and has published over 170 peer-reviewed, high-impact papers in prestigious journals such as Nature/Science/PNAS/Cell Press family journals. He has received multiple awards/grants including the DoD RTRP Investigator-Initiated Research Award, DoD LRP Idea Award, NIH P01, American Heart Association (AHA) Transformational Project Award, American Lung Association (ALA) Courtney Cox Cole Lung Cancer Research Award, AHA Collaborative Sciences Award, ALA Cancer Discovery Award, LEO Foundation Research Grant, Novo Nordisk ValidatioNN Award, American Society of Transplantation (AST) Career Transition Grant (Translational Science), Harvard Catalyst - Cores Facility Program, Harvard/Brigham Health Technology Innovator Award, Distinguished Chair Professorship Foundation, Anaesthesia Department Basic Scientist Grant, Khoury Innovation Award, Center for Nanomedicine Research Fund, Nanotechnology Foundation, Stepping Strong Breakthrough Innovator Award, AHA's Second Century Early Faculty Independence Award, U.S. METAvivor Early Career Investigator Award, MIT Technology Review Top Chinese Innovators (2020 TR35), World's Top 2% Scientist (Year-List since 2019; Career-List since 2023), Chemical Society Reviews Emerging Investigator Lectureship Award, Materials Today Rising Star Award, Advanced Materials Rising Star, Biomaterials Award for Young Investigator, Angewandte Chemie Most Outstanding Referees Award, Materials Horizons Top 10 Outstanding Reviewers Award, and so on. In 2025, he was inducted as a Member of Academia Europaea (MAE) and a Fellow into the American Institute for Medical and Biological Engineering (AIMBE).

He has served on the scientific committee as either an invited award nominator or an invited grant reviewer for NIH (US), DoD (US), European Research Council, Deutsche Forschungsgemeinschaft (German Research Foundation), Swiss National Science Foundation (Switzerland), Dutch Research Council (Netherlands), Israel Science Foundation (Israel), Canadian Institutes of Health Research (Canada), The Xplorer Prize (China), JDRF (Type 1 Diabetes Grand Challenge, UK), VinFuture Prize (VinFuture Foundation, Vietnam), MIT Technology Review Innovators Under 35 (TR35), etc. He also serves or has served on numerous editorial boards including as Founding Editor-in-Chief of Biomedical Technology (Elsevier & KeAi's new journal), Deputy Editor of Exploration (Wiley's new journal), Associate Editor of Journal of Nanobiotechnology (Springer Nature & BMC) and Aggregate (Wiley); Editor of PNAS; Guest Editor of eLife, etc.; Senior Editorial Board Member of Materials Today (Elsevier), Bioactive Materials (Elsevier & KeAi), Nano-Micro Letters (Springer Nature), etc.; and Advisory Board Member of Matter (Cell Press).